These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 25011259)
21. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification. Qi F; Wu J; Yang T; Ma G; Su Z Acta Biomater; 2014 Oct; 10(10):4247-56. PubMed ID: 24952071 [TBL] [Abstract][Full Text] [Related]
22. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
24. A novel and simple preparative method for uniform-sized PLGA microspheres: Preliminary application in antitubercular drug delivery. Liu Z; Li X; Xiu B; Duan C; Li J; Zhang X; Yang X; Dai W; Johnson H; Zhang H; Feng X Colloids Surf B Biointerfaces; 2016 Sep; 145():679-687. PubMed ID: 27289309 [TBL] [Abstract][Full Text] [Related]
25. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Doan TV; Couet W; Olivier JC Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123 [TBL] [Abstract][Full Text] [Related]
26. [Preparation of alginate-chitosan-poly (lactic-co-glycolic acid) composite microsphere and its regulation of protein release]. Zheng CH; Liang WQ; Yu HY Yao Xue Xue Bao; 2005 Feb; 40(2):182-6. PubMed ID: 15875679 [TBL] [Abstract][Full Text] [Related]
27. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. Ohashi K; Kabasawa T; Ozeki T; Okada H J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349 [TBL] [Abstract][Full Text] [Related]
28. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres. Yang Y; Gao Y; Mei X Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467 [TBL] [Abstract][Full Text] [Related]
29. A novel preparation method for PLGA microspheres using non-halogenated solvents. Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036 [TBL] [Abstract][Full Text] [Related]
30. Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. Ito F; Honnami H; Kawakami H; Kanamura K; Makino K Colloids Surf B Biointerfaces; 2008 Nov; 67(1):20-5. PubMed ID: 18774278 [TBL] [Abstract][Full Text] [Related]
31. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
32. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
33. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering. Andreas K; Zehbe R; Kazubek M; Grzeschik K; Sternberg N; Bäumler H; Schubert H; Sittinger M; Ringe J Acta Biomater; 2011 Apr; 7(4):1485-95. PubMed ID: 21168535 [TBL] [Abstract][Full Text] [Related]
34. Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Schaefer MJ; Singh J AAPS PharmSciTech; 2000 Nov; 1(4):E32. PubMed ID: 14727897 [TBL] [Abstract][Full Text] [Related]
35. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres. Zhao K; Li GX; Jin YY; Wei HX; Sun QS; Huang TT; Wang YF; Tong GZ J Microencapsul; 2010; 27(2):178-86. PubMed ID: 20121488 [TBL] [Abstract][Full Text] [Related]
36. [Preparation and properties of Talpha1 loaded injectable sustained release microspheres]. Zhu Y; Lu Y; Zhong YQ Yao Xue Xue Bao; 2007 Feb; 42(2):211-5. PubMed ID: 17518054 [TBL] [Abstract][Full Text] [Related]
37. About mean diameter and size distributions of poly(lactide-co-glycolide) (PLG) microspheres. Berchane NS; Jebrail FF; Carson KH; Rice-Ficht AC; Andrews MJ J Microencapsul; 2006 Aug; 23(5):539-52. PubMed ID: 16980275 [TBL] [Abstract][Full Text] [Related]
38. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Doan TV; Olivier JC Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562 [TBL] [Abstract][Full Text] [Related]
39. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres. Chen W; Palazzo A; Hennink WE; Kok RJ Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854 [TBL] [Abstract][Full Text] [Related]
40. Solvent hydrolysis rate determines critical quality attributes of PLGA microspheres prepared using non-volatile green solvent. Kim H; Kim S; Sah H J Biomater Sci Polym Ed; 2018 Jan; 29(1):35-56. PubMed ID: 29086633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]